ST
Stemtech Corporation
STEK · OTC
$0.00 -0.00% (-$0.00)
1M +0.00%
Market Cap $216.9K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0001
Undervalued Fair Value Overvalued
According to Bulios Fair Price, STEK is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/S 0.09x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 14.23%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 77.27%
Net margin 159.69%
Op. margin 98.82%
Quality
71 /100
Excellent ROIC 22.72%
ROA 121.29%
Asset turnover 0.76x
Debt
0 /100
High Current ratio 0.05x
Int. coverage -24.93x
Debt/Equity N/A
Stability
37 /100
Moderate Beta 2.58x
Rev. volatility 28.07%
EPS volatility 20.56%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about STEK
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Charles S. Arnold
Employees
1
Headquarters
Naples